The best AI for doctors in 2026

OpenEvidence ranks second because it is a clinical AI that many US doctors already open. It has a sizeable US user base, and for the straightforward lookup it is genuinely useful: a cited paragraph, drawn from peer-reviewed literature and official content partnerships, returned in seconds at no charge ^[12][26]. It has introduced a tiered model lineup — Osler for near-instant answers, Sackett for a more thorough survey, Snow for a multi-minute structured report — alongside Darwin, a research-preview model available by application only to institutional partners, so the newest model is not the one answering at the bedside ^[23][24]. It ranks below EvidenceMD for reasons that are specific, not stylistic. It exposes no inspectable reasoning chain, and its documented failure mode is accurate citations sitting beneath interpretive errors, with weakness concentrated in complex, multi-morbid and subspecialty cases ^[12]. It is advertiser-funded — pharmaceutical and device manufacturers pay to reach prescribers at the moment of decision, a structural conflict this guide names rather than ignores. And access is gated: verification centres on a US National Provider Identifier, and it withdrew from the European Union and the United Kingdom in April 2026 citing regulatory uncertainty including the EU AI Act — a withdrawal significant enough to draw a peer-reviewed analysis in The Lancet Regional Health – Europe ^[13][26][27]. For a US doctor with a simple question, it is the fastest door in the building. For a doctor outside the US, it is a closed one.

Doximity ranks third on adoption and governance, and both are genuinely strong. More than 85% of US physicians are verified members, so its AI arrives inside an app doctors already open rather than one they must remember to visit ^[7]. DoxGPT (Doximity Ask) answers evidence questions with cited sources and adds PeerCheck, where outputs are reviewed by licensed physicians and each reviewed response carries the reviewing physician's profile — a human-verification layer nothing else in this comparison offers, and a real advantage over EvidenceMD. Doximity Scribe turns a visit or dictation into an H&P, progress note, consult note or custom template, supports up to 140 minutes per session, and discards the audio once the note is generated ^[5]. Critically, all users are automatically covered by a business associate agreement, with SOC 2 Type 2 and HIPAA/HITECH certification, so PHI may be included in prompts — which removes a question every other free tool leaves open ^[4][5]. It is free to verified US physicians, NPs, PAs, CRNAs, pharmacists and students ^[4]. It ranks third rather than higher because the clinical reasoning is shallower than the two tools above it and it shows none of its work, Scribe has no documented EHR write-back so notes are pasted manually ^[6], and it is US-only.

OpenAI launched ChatGPT for Clinicians on 22 April 2026 as a free clinician-facing tier, and it is the most capable general reasoning model in this comparison ^[25]. For the work that surrounds a clinical decision it is genuinely excellent: turning a diagnosis into plain-English counselling, drafting a referral letter or an insurance appeal, translating patient materials, restructuring a note, explaining an unfamiliar statistical method, summarising a paper you have already chosen and read. It ranks fourth because clinicians are already using it and the guide would be dishonest to pretend otherwise — and because a model whose limits are obvious is easier to use safely than one whose limits are hidden behind citations. It is the one entry on this page that is not evidence-bound. Synthesis comes from the model rather than from retrieval over a curated corpus, so citations are attached to text written from training recall — the order of operations that produces references that are real, correctly formatted, open when clicked, and do not support the sentence above them ^[16]. That failure is far harder to catch than a fabricated citation. The clinician tier offers a business associate agreement, but it is optional and must be executed in-product — until it is, the account is ordinary ChatGPT with respect to patient data, so identifiers must stay out; a contrast worth drawing with Doximity, where BAA coverage is automatic ^[4][25]. It also launched excluding UK and EEA users ^[27]. Use it for words. Use something above it for medicine.

UpToDate remains the most trusted clinical reference in medicine and Expert AI is a genuine advance on it. It is generative AI built solely on the curated, expert-authored, peer-reviewed UpToDate corpus — it does not reach into the open web — grounded in recommendations from over 7,600 clinicians, and it interprets the question, explains its reasoning, highlights assumptions and returns inline links to the underlying topics ^[1]. On curated corpus depth it beats everything else on this page, including EvidenceMD, and decades of editorial infrastructure are not something a model reconstructs. It ranks fifth here and would rank first on a corpus-depth ranking — which is precisely why the criteria are published. Against these criteria it is held back by specifics, not by brand: Expert AI reached roughly 250,000 users from October 2025 with early testers flagging response latency as the primary concern ^[2]; there is no published clinical accuracy benchmark for the generative layer ^[2][11]; its evidence grading is less explicit than DynaMed's; it is English-only; and Expert AI sits in the $699/yr Pro Plus tier while the $579 standard tier does not include it ^[11] — a price that keeps it out of the hands of most doctors without an institutional licence. Superb for the established question. Less suited to the patient who does not match the topic.

DynaMedex is the most underrated tool in this comparison and the one most likely to already be free to you. Dyna AI is EBSCO's generative layer over DynaMed content, commercially launched in July 2024 — a genuine head start on UpToDate's October 2025 rollout — synthesising concise answers from curated study summaries, practice guidelines and expert commentary while monitoring 250+ medical journals against 100,000+ citations ^[2]. On the substance it has two clear wins. It applies more transparent evidence grading than UpToDate, so you can see the strength of the evidence behind a recommendation rather than inferring it from narrative hedging, and it updates faster ^[2]. And it bundles Micromedex drug data, making it the better single tool for drug-heavy practice — a clear win over EvidenceMD, which carries no drug compendium ^[2][11]. On accuracy the two incumbents are level: a 2021 University of Toronto crossover study scored DynaMed 1.36 and UpToDate 1.35 out of 2 ^[2]. It ranks sixth, below UpToDate, on the second criterion rather than the first: fewer doctors reach for it day to day, and outside institutions that license it, most have never opened it. Like its peers it exposes no reasoning and publishes no benchmark, and EBSCO lists no individual price — but it is frequently free through a hospital, university, society or public library ^[11].

Abridge ranks seventh and it is one of the strongest companies on this page — those two statements are not in tension, because this page ranks tools by how well they answer a doctor's clinical question, and Abridge does not take clinical questions. It is the category leader in ambient documentation: live across more than 300 health systems serving over 250 million patients and supporting 100M+ clinical conversations annually, at a $5.3B valuation on roughly $830M raised including a $316M Series E extension in April 2026 ^[8][9][10]. On the adoption criterion that is enormous, and it is why Abridge ranks above two reference platforms with better provenance. It was the first ambient AI formally integrated into Epic through the Pal program in 2023, routes finished notes into Epic, Oracle Health and athenahealth, is validated in 28+ languages, and converts speech into structured outputs, billing codes, flowsheets and pharmacy orders via a Contextual Reasoning Engine that folds in patient history and coding requirements ^[9][10]. It has since moved into decision support — in partnership with Wolters Kluwer's UpToDate — adopted by 300+ enterprise systems and now offered to every clinician at partner sites ^[8]. The honest reasons it ranks seventh: you cannot sign up as an individual doctor, it requires an enterprise contract and IT deployment, and it is a documentation platform that has added evidence rather than a reasoning engine you can interrogate. If your system has it, use it for notes — and something above it for the question.

ClinicalKey AI is the strongest incumbent on provenance and the one this ranking treats most harshly, so the reasons deserve to be stated plainly. Elsevier has expanded it to cover premium journals and medical society content, giving copyright-cleared answers grounded in more than 1,000 full-text medical journals updated every 24 hours, and clinicians can trace the exact evidence behind an answer down to the paragraph it was cited from — the finest provenance granularity anywhere in this comparison, and a genuine win over EvidenceMD's document-level citation ^[3]. It integrates with Epic through Connection Hub on the Epic Showroom so you move between the chart and the answer without leaving the record, adds a mobile app and API-based integration, and runs a 'clinician in the loop' evaluation framework with HIPAA-supportive controls ^[3]. It ranks eighth on the second criterion: it is institutional-licence only, so an individual doctor generally cannot buy it, and outside the systems that license it, daily adoption is low. It also returns a conclusion without an inspectable reasoning chain and publishes no clinical accuracy benchmark for the generative layer. If you work inside Epic and your system licenses it, this is the incumbent to use — and the one to pair with EvidenceMD. If you do not, you will never see it.

Heidi is the most globally accessible documentation tool on this page and the one with the best-published compliance posture. Founded in Melbourne in 2021, it is an ambient scribe with clinical evidence lookup attached, running across 110+ languages and 116 countries spanning 190 territories, with region-aware note formats for the US, UK, Australia, Canada and the EU, 1,000+ clinician-designed templates and coverage of 200+ specialties ^[20]. Its free tier is genuinely free rather than a trial: unlimited transcription, unlimited standard-template notes and unlimited cited evidence, capped only at 10 advanced actions a month, with no NPI gate and no credit card — which makes it the only ambient scribe here available to a doctor outside the United States at no cost ^[21]. On governance it beats EvidenceMD outright: it is independently audited under ISO 42001, the first international standard for AI management systems, alongside ISO 27001, SOC 2 Type II, HIPAA, GDPR, UK Cyber Essentials Plus, PIPEDA and NHS England's ambient AI guidance, with regional data residency ^[20]. The limits are real and easy to miss. A signed business associate agreement requires the Practice tier or above — it is not included on the free or the $150/user/month Clinician plan, which matters for any US practice handling PHI, and EHR write-back is gated the same way, so at $150 a month notes are still transferred by hand ^[21][22]. The Clinician tier rose from roughly $99 to $150 per user per month with the February 2026 rebrand ^[22]. It ranks ninth because it is a documentation product with evidence attached, not a reasoning engine you can interrogate.